Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Jonsson Comprehensive Cancer Center
UNICANCER
Hackensack Meridian Health
Intergroupe Francophone de Cancerologie Thoracique
Second Affiliated Hospital of Nanchang University
Dana-Farber Cancer Institute
Swiss Cancer Institute
University of Utah
Abramson Cancer Center at Penn Medicine
Fundación GECP
Sun Yat-sen University
University of Iowa
Intergroupe Francophone de Cancerologie Thoracique
Rutgers, The State University of New Jersey
Università Vita-Salute San Raffaele
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Fundación GECP
Intergroupe Francophone de Cancerologie Thoracique
Washington University School of Medicine
Weill Medical College of Cornell University
Duke University
NRG Oncology
University of Alabama at Birmingham
First Affiliated Hospital of Zhejiang University
Gustave Roussy, Cancer Campus, Grand Paris
Shanghai Junshi Bioscience Co., Ltd.
Peking University Cancer Hospital & Institute
Shanghai Junshi Bioscience Co., Ltd.
Samsung Medical Center
Stanford University
Fundación GECP
Fundación GECP
Fundación GECP
Fox Chase Cancer Center
Latin American Cooperative Oncology Group
Tufts Medical Center
Spanish Lung Cancer Group
Xiangya Hospital of Central South University
Hunan Province Tumor Hospital
University of Michigan Rogel Cancer Center
University of Iowa
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Shanghai Junshi Bioscience Co., Ltd.
Tang-Du Hospital
State University of New York - Upstate Medical University
Sun Yat-sen University
Albert Einstein College of Medicine